Recombinant GCGR (Crotedumab Biosimilar) antibody

Catalog No. ABIN7675750

The Human Monoclonal anti-GCGR (Crotedumab Biosimilar) antibody is suitable to detect GCGR (Crotedumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant GCGR (Crotedumab Biosimilar) antibody (ABIN7675750)

Target: GCGR (Crotedumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This GCGR (Crotedumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-GCGR (Crotedumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-GCGR Reference Antibody (crotedumab)

Characteristics: Anti-GCGR Reference Antibody (crotedumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for GCGR (Crotedumab Biosimilar)

Target: GCGR (Crotedumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P47871